TrialCancer immunology, immunotherapy : CII2014

Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome.

David M Foureau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.